Human folate receptor alpha Recombinant Rabbit mAb (SDT-719-20-2)

產(chǎn)品型號(hào)：S0B2275

更新時(shí)間：2025-10-10

廠商性質(zhì)：生產(chǎn)廠家

訪問量：81

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

生物標(biāo)志物新星：多面手GDF-15

重組兔單抗：解鎖生命科學(xué)研究新大門的神奇鑰匙

Flag 標(biāo)簽與抗體：蛋白研究的精準(zhǔn)定位 “組合拳”

蛋白乙?；芯咳ヂ裕簭男揎棸l(fā)現(xiàn)到功能解析的完整路徑

產(chǎn)品介紹

Folate receptor 1 （Folate receptor alpha, FOLR1） is a protein that in humans is encoded by the FOLR1 gene.
The protein encoded by this gene is a member of the folate receptor （FOLR） family. Members of this family have a high affinity for folic acid and for several reduced folic acid derivatives, and mediate delivery of 5-methyltetrahydrofolate to the interior of cells. FRα, due to its high expression in some tumors, is an attractive therapeutic target for the development of novel anti-cancer agents in order to limit toxic side-effects on off-target tissues. FRa can be overexpressed by a number of epithelial-derived tumors including ovarian, breast, renal, lung, colorectal, and brain. Therefore, antibodies to FRa are being developed for use in targeted therapies, with one example being farletuzumab, in a phase III trial for ovarian cancer.

上一個(gè)：S0B0400Claudin 6 Recombinant Rabbit mAb (S-521-63)